JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5626
VEON
VEON
$5.09B
| $48.6K | ﹤0.01% |
1,872
-112
| -6% | -$2.8K |
2013 Q2
44 quarters
|
|
5627
Alpha Architect International Quantitative Value ETF
IVAL
$218M
| $48.5K | ﹤0.01% |
1,945
-1,695
| -47% | -$44.2K |
2023 Q4
2 quarters
|
|
|
WCBR
5628
WisdomTree Cybersecurity Fund
WCBR
$173M
| $48.2K | ﹤0.01% |
+1,918
| New | +$46.8K |
2024 Q2
0 quarters
|
|
5629
First Trust Europe AlphaDEX Fund
FEP
$497M
| $48.1K | ﹤0.01% |
1,306
+30
| +2% | +$1.14K |
2022 Q4
6 quarters
|
|
5630
Geospace Technologies
GEOS
$61.7M
| $48.1K | ﹤0.01% |
5,353
-17,661
| -77% | -$199K |
2023 Q4
2 quarters
|
|
|
RGLS
5631
DELISTED
Regulus Therapeutics
RGLS
| $48K | ﹤0.01% |
26,913
+7,171
| +36% | +$16.6K |
2023 Q3
3 quarters
|
|
5632
Priority Technology Holdings
PRTH
$642M
| $48K | ﹤0.01% |
9,089
-20,937
| -70% | -$79.2K |
2018 Q1
25 quarters
|
|
|
GTHX
5633
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $47.9K | ﹤0.01% |
21,029
-33,605
| -62% | -$128K |
2017 Q4
26 quarters
|
|
5634
Design Therapeutics
DSGN
$766M
| $47.5K | ﹤0.01% |
14,184
-24,520
| -63% | -$95.5K |
2021 Q2
12 quarters
|
|
5635
Veru
VERU
$43.3M
| $47.4K | ﹤0.01% |
5,639
+5,630
| +62,556% | +$65.1K |
2018 Q1
25 quarters
|
|
5636
Q32 Bio
QTTB
$246M
| $47K | ﹤0.01% |
2,620
+2,569
| +5,037% | +$61.5K |
2018 Q1
25 quarters
|
|
5637
CALL
Herbalife
HLF
$1.29B
| $46.8K | ﹤0.01% |
+4,500
| New | +$45K |
2024 Q2
0 quarters
|
|
5638
Smartbird Inc
BIRD
$41.2M
| $46.6K | ﹤0.01% |
4,662
-1,832
| -28% | -$22.4K |
2021 Q4
10 quarters
|
|
5639
SKYX Platforms
SKYX
$154M
| $46.6K | ﹤0.01% |
49,079
+22,277
| +83% | +$21.8K |
2023 Q2
4 quarters
|
|
5640
State Street SPDR MSCI EAFE StrategicFactors ETF
QEFA
$995M
| $46.5K | ﹤0.01% |
+622
| New | +$47K |
2024 Q2
0 quarters
|
|
5641
LiveOne
LVO
$35.4M
| $45.9K | ﹤0.01% |
2,924
-3,438
| -54% | -$60.8K |
2018 Q2
24 quarters
|
|
5642
Compass Therapeutics
CMPX
$162M
| $45.9K | ﹤0.01% |
45,883
+7,530
| +20% | +$11K |
2023 Q1
5 quarters
|
|
5643
INmune Bio
INMB
$53.6M
| $45.9K | ﹤0.01% |
+5,202
| New | +$51.3K |
2024 Q2
0 quarters
|
|
5644
Quantum-Si Incorporated
QSI
$313M
| $45.8K | ﹤0.01% |
43,659
+1,377
| +3% | +$2.21K |
2021 Q4
10 quarters
|
|
5645
Taylor Devices
TAYD
$197M
| $45.7K | ﹤0.01% |
+1,015
| New | +$49.2K |
2024 Q2
0 quarters
|
|
5646
Invesco S&P SmallCap Energy ETF
PSCE
$104M
| $45.6K | ﹤0.01% |
868
-43
| -5% | -$2.34K |
2022 Q4
6 quarters
|
|
5647
Direxion Daily Energy Bull 2X ETF
ERX
$240M
| $45.6K | ﹤0.01% |
700
-48
| -6% | -$3.28K |
2021 Q1
13 quarters
|
|
5648
Lifetime Brands
LCUT
$199M
| $45.5K | ﹤0.01% |
5,301
-33,712
| -86% | -$338K |
2013 Q2
44 quarters
|
|
5649
ProShares UltraPro Short Dow 30
SDOW
$156M
| $45.5K | ﹤0.01% |
684
-226
| -25% | -$15.5K |
2023 Q4
2 quarters
|
|
5650
iShares Genomics Immunology and Healthcare ETF
IDNA
$285M
| $45.4K | ﹤0.01% |
1,964
+1,624
| +478% | +$38K |
2024 Q1
1 quarter
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.